Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
PLETHICO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs254320-   
Low Rs31231-   
Sales per share (Unadj.) Rs604.695.1-  
Earnings per share (Unadj.) Rs32.5-24.0-  
Cash flow per share (Unadj.) Rs51.3-19.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs473.774.6-  
Shares outstanding (eoy) m34.07168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.22.9 8.2%   
Avg P/E ratio x4.4-11.5 -38.2%  
P/CF ratio (eoy) x2.8-13.9 -20.0%  
Price / Book Value ratio x0.33.7 8.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,85946,446 10.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,5472,915 53.1%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m20,59816,052 128.3%  
Other income Rs m419112 373.2%   
Total revenues Rs m21,01716,165 130.0%   
Gross profit Rs m2,938-2,782 -105.6%  
Depreciation Rs m642693 92.7%   
Interest Rs m1,747435 401.7%   
Profit before tax Rs m968-3,797 -25.5%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138237 -58.3%   
Profit after tax Rs m1,107-4,045 -27.4%  
Gross profit margin %14.3-17.3 -82.3%  
Effective tax rate %-14.3-6.2 228.7%   
Net profit margin %5.4-25.2 -21.3%  
BALANCE SHEET DATA
Current assets Rs m18,87711,757 160.6%   
Current liabilities Rs m11,8966,615 179.8%   
Net working cap to sales %33.932.0 105.8%  
Current ratio x1.61.8 89.3%  
Inventory Days Days78111 70.4%  
Debtors Days Days198124 159.6%  
Net fixed assets Rs m14,2696,853 208.2%   
Share capital Rs m34175 457.1%   
"Free" reserves Rs m15,7980-   
Net worth Rs m16,13912,599 128.1%   
Long term debt Rs m4,7064,428 106.3%   
Total assets Rs m33,14623,801 139.3%  
Interest coverage x1.6-7.7 -20.1%   
Debt to equity ratio x0.30.4 83.0%  
Sales to assets ratio x0.60.7 92.1%   
Return on assets %8.6-15.2 -56.8%  
Return on equity %6.9-32.1 -21.4%  
Return on capital %13.0-19.8 -65.8%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,4371,370 177.9%  
From Investments Rs m-6,265-421 1,489.1%  
From Financial Activity Rs m2,4904,018 62.0%  
Net Cashflow Rs m244,968 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare PLETHICO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PLETHICO PHARMA With: DECIPHER LABS  ALBERT DAVID  IND SWIFT LA  BDH INDUS.  GANGA PHARMACEUTICALS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.